New drugs for Clostridium difficile infection
- PMID: 16838230
- DOI: 10.1086/506387
New drugs for Clostridium difficile infection
Comment on
-
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.Clin Infect Dis. 2006 Aug 15;43(4):411-20. doi: 10.1086/506349. Epub 2006 Jul 11. Clin Infect Dis. 2006. PMID: 16838228 Clinical Trial.
-
Nitazoxanide for the treatment of Clostridium difficile colitis.Clin Infect Dis. 2006 Aug 15;43(4):421-7. doi: 10.1086/506351. Epub 2006 Jul 11. Clin Infect Dis. 2006. PMID: 16838229 Clinical Trial.
Similar articles
-
Bad bugs, no drugs: no ESCAPE revisited.Clin Infect Dis. 2009 Sep 15;49(6):992-3. doi: 10.1086/605539. Clin Infect Dis. 2009. PMID: 19694542 No abstract available.
-
[Clostridium difficile infections: an unexpected re-emergence].Pathol Biol (Paris). 2008 Feb;56(1):6-9. doi: 10.1016/j.patbio.2007.09.017. Pathol Biol (Paris). 2008. PMID: 18178330 French. No abstract available.
-
The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.Clin Infect Dis. 2008 May 15;46(10):1489-92. doi: 10.1086/587654. Clin Infect Dis. 2008. PMID: 18419480 Review. No abstract available.
-
Antibiotics and Clostridium difficile: cause and cure.J Clin Gastroenterol. 2007 Jan;41(1):1-2. doi: 10.1097/01.mcg.0000225619.24965.aa. J Clin Gastroenterol. 2007. PMID: 17198057 No abstract available.
-
Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea.Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):295-305. doi: 10.1586/17474124.1.2.295. Expert Rev Gastroenterol Hepatol. 2007. PMID: 19072422 Review.
Cited by
-
Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).Rev Esp Quimioter. 2020 Apr;33(2):151-175. doi: 10.37201/req/2065.2020. Epub 2020 Feb 20. Rev Esp Quimioter. 2020. PMID: 32080996 Free PMC article.
-
Lack of Association Between the Clinical Outcome of Clostridium difficile Infection and Current Steroids Use.Gastroenterology Res. 2017 Apr;10(2):116-119. doi: 10.14740/gr822w. Epub 2017 Apr 19. Gastroenterology Res. 2017. PMID: 28496532 Free PMC article.
-
MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.Antimicrob Agents Chemother. 2012 Sep;56(9):4786-92. doi: 10.1128/AAC.00508-12. Epub 2012 Jun 25. Antimicrob Agents Chemother. 2012. PMID: 22733075 Free PMC article.
-
Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.Antimicrob Agents Chemother. 2012 Apr;56(4):1974-8. doi: 10.1128/AAC.05647-11. Epub 2012 Jan 17. Antimicrob Agents Chemother. 2012. PMID: 22252830 Free PMC article.
-
Current Treatment Options for Severe Clostridium difficile-associated Disease.Gastroenterol Hepatol (N Y). 2008 Feb;4(2):134-9. Gastroenterol Hepatol (N Y). 2008. PMID: 21904490 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
